Immunoprecise Antibodies Ltd.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 19 institutions reported holding Immunoprecise Antibodies Ltd. in their 13F filings, down 3 from Q1 2024. 2 opened new positions and 5 sold out. The largest holders were Ingalls & Snyder LLC ($1.3M), Renaissance Technologies ($65K) and Bank of Montreal ($61K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Immunoprecise Antibodies Ltd.
- CUSIP
- 45257F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $18K |
| Exits | 5 | $131K |
All 13F filers, Q1 2024 → Q2 2024: 74,445 shares bought and 90,747 shares sold, net −16,302 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Ingalls & Snyder LLC | 0.06% | Add +0.5% | 1,295,441 | $1.3M |
| Renaissance Technologies | 0.00% | Add +70.0% | 63,910 | $65K |
| Bank of Montreal | 0.00% | Add +3.8% | 55,857 | $61K |
| Northern Trust Corp. | 0.00% | Reduce -6.0% | 50,730 | $51K |
| Cibc World Market Inc. | 0.00% | No change | 41,200 | $42K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +22.7% | 27,033 | $27K |
| Gradient Capital Advisors, LLC | 0.01% | No change | 26,808 | $27K |
| Geode Capital Management, LLC | 0.00% | No change | 17,484 | $18K |
| Rathbones Group PLC | 0.00% | No change | 14,000 | $14K |
| XTX Topco Ltd | 0.00% | New | 12,695 | $13K |
| UBS Group AG | 0.00% | Add +393.6% | 12,232 | $12K |
| Morgan Stanley | 0.00% | No change | 10,533 | $11K |
| Mariner, LLC | 0.00% | No change | 10,000 | $10K |
| Simplex Trading, LLC | 0.00% | Add +661.8% | 7,648 | $7K |
| Citadel Advisors | 0.00% | New | 5,084 | $5K |
| Group One Trading LLC | 0.00% | Reduce -36.3% | 2,408 | $2K |
| West Paces Advisors Inc. | 0.00% | No change | 1,665 | $2K |
| National Bank of Canada | 0.00% | No change | 1,540 | $1K |
| Citigroup Inc. | 0.00% | No change | 7 | $7 |
"% of holder's portfolio" is IMMUNOPRECISE ANTIBODIES LTD's weight in each manager's 13F, not the share of Immunoprecise Antibodies Ltd. the manager owns.